[Effect of 1,25-dihydroxyvitamin D3 on 15-lipoxygenase activity]. 1995

L B Bondarenko, and O V Kharchenko, and I A Butovich

The influence of 1.25-dihydroxyvitamin D3 on soybean 15-lipoxygenase activity was studied in vitro. 1.25-Dihydroxyvitamin D3 inhibited enzymatic activity in relation to its dose, pH and substrate (linoleic acid) concentration; the findings are indicative of a mixed type of inhibition.

UI MeSH Term Description Entries
D008041 Linoleic Acids Eighteen-carbon essential fatty acids that contain two double bonds. Acids, Linoleic
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D013025 Glycine max An annual legume. The SEEDS of this plant are edible and used to produce a variety of SOY FOODS. Soy Beans,Soybeans,Bean, Soy,Beans, Soy,Soy Bean,Soybean
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D016859 Lipoxygenase Inhibitors Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. 5-Lipoxygenase Inhibitor,Lipoxygenase Inhibitor,12-Lipoxygenase Inhibitors,15-Lipoxygenase Inhibitors,5-Lipoxygenase Inhibitors,Arachidonate 12-Lipoxygenase Inhibitors,Arachidonate 15-Lipoxygenase Inhibitors,Arachidonate 5-Lipoxygenase Inhibitors,Inhibitors, Lipoxygenase,12 Lipoxygenase Inhibitors,12-Lipoxygenase Inhibitors, Arachidonate,15 Lipoxygenase Inhibitors,15-Lipoxygenase Inhibitors, Arachidonate,5 Lipoxygenase Inhibitor,5 Lipoxygenase Inhibitors,5-Lipoxygenase Inhibitors, Arachidonate,Arachidonate 12 Lipoxygenase Inhibitors,Arachidonate 15 Lipoxygenase Inhibitors,Arachidonate 5 Lipoxygenase Inhibitors,Inhibitor, 5-Lipoxygenase,Inhibitor, Lipoxygenase,Inhibitors, 12-Lipoxygenase,Inhibitors, 15-Lipoxygenase,Inhibitors, 5-Lipoxygenase,Inhibitors, Arachidonate 12-Lipoxygenase,Inhibitors, Arachidonate 15-Lipoxygenase,Inhibitors, Arachidonate 5-Lipoxygenase
D019787 Linoleic Acid A doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. (From Stedman, 26th ed) 9,12-Octadecadienoic Acid,Linoleate,9-trans,12-trans-Octadecadienoic Acid,Linoelaidic Acid,Linoelaidic Acid, (E,Z)-Isomer,Linoleic Acid, (E,E)-Isomer,Linoleic Acid, (Z,E)-Isomer,Linoleic Acid, (Z,Z)-Isomer,Linoleic Acid, (Z,Z)-Isomer, 14C-Labeled,Linoleic Acid, Ammonium Salt, (Z,Z)-Isomer,Linoleic Acid, Calcium Salt, (Z,Z)-Isomer,Linoleic Acid, Potassium Salt, (Z,Z)-Isomer,Linoleic Acid, Sodium Salt, (E,E)-Isomer,Linoleic Acid, Sodium Salt, (Z,Z)-Isomer,Linolelaidic Acid,cis,cis-9,12-Octadecadienoic Acid,trans,trans-9,12-Octadecadienoic Acid,9 trans,12 trans Octadecadienoic Acid,9,12 Octadecadienoic Acid,Acid, 9,12-Octadecadienoic

Related Publications

L B Bondarenko, and O V Kharchenko, and I A Butovich
May 1981, Diabetes,
L B Bondarenko, and O V Kharchenko, and I A Butovich
April 1983, Horumon to rinsho. Clinical endocrinology,
L B Bondarenko, and O V Kharchenko, and I A Butovich
March 1988, The Biochemical journal,
L B Bondarenko, and O V Kharchenko, and I A Butovich
March 1986, Methods and findings in experimental and clinical pharmacology,
L B Bondarenko, and O V Kharchenko, and I A Butovich
May 1991, The Journal of laboratory and clinical medicine,
L B Bondarenko, and O V Kharchenko, and I A Butovich
May 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
L B Bondarenko, and O V Kharchenko, and I A Butovich
December 1989, Proceedings of the National Academy of Sciences of the United States of America,
L B Bondarenko, and O V Kharchenko, and I A Butovich
February 1983, The American journal of physiology,
Copied contents to your clipboard!